The National Medical Products Administration (NMPA) in China oversees the Drug Master Files (DMFs) by evaluating and approving the quality, safety, and efficacy of pharmaceutical ingredients and products. It ensures compliance with regulatory standards, facilitates market access, and maintains public health by monitoring manufacturing practices and product consistency.